Clinical Trials
HCC clinical trials currently enrolling patients. Bring the NCT number to your next oncology appointment to ask if you may be eligible.
NCT07884877Recruiting
PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer
Updated: Oct 21, 2026
View on ClinicalTrials.gov
NCT07808164Recruiting
ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort
Updated: Oct 26, 2026
View on ClinicalTrials.gov
NCT07760012Recruiting
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
Updated: Oct 15, 2026
View on ClinicalTrials.gov
NCT07749586Recruiting
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Updated: Oct 13, 2026
View on ClinicalTrials.gov
NCT07714538Recruiting
Breath Research Narrow Validation for Gastrointestinal Cancer Detection
Updated: Oct 22, 2026
View on ClinicalTrials.gov
NCT07650773Recruiting
CHARM Hepatocellular Carcinoma MEA Study
Updated: Oct 14, 2026
View on ClinicalTrials.gov
NCT07590336Recruiting
68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma
Updated: Oct 21, 2026
View on ClinicalTrials.gov
NCT07487662Recruiting
TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk
Updated: Oct 27, 2026
View on ClinicalTrials.gov
NCT07419841Recruiting
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Updated: Oct 23, 2026
View on ClinicalTrials.gov
NCT07405086Recruiting
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Updated: Oct 13, 2026
View on ClinicalTrials.gov
NCT07377487Recruiting
TheraSphere Japan Pre-Market Study
Updated: Oct 21, 2026
View on ClinicalTrials.gov
NCT07291076Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Updated: Oct 23, 2026
View on ClinicalTrials.gov
NCT07197554Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Updated: Oct 27, 2026
View on ClinicalTrials.gov
NCT07062055Recruiting
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Updated: Oct 15, 2026
View on ClinicalTrials.gov
NCT07053072Recruiting
PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
Updated: Oct 13, 2026
View on ClinicalTrials.gov
NCT07042919Recruiting
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Updated: Oct 23, 2026
View on ClinicalTrials.gov
NCT07036874Recruiting
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Updated: Oct 20, 2026
View on ClinicalTrials.gov
NCT06921785Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Updated: Oct 13, 2026
View on ClinicalTrials.gov
NCT06915753Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Updated: Oct 14, 2026
View on ClinicalTrials.gov
NCT06841172Recruiting
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
Updated: Oct 13, 2026
View on ClinicalTrials.gov
NCT06811116Recruiting
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Updated: Oct 26, 2026
View on ClinicalTrials.gov
NCT06795022Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Updated: Oct 14, 2026
View on ClinicalTrials.gov
NCT06789757Recruiting
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
Updated: Oct 16, 2026
View on ClinicalTrials.gov
NCT06764316Recruiting
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
Updated: Oct 21, 2026
View on ClinicalTrials.gov
NCT06644430Recruiting
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
Updated: Oct 23, 2026
View on ClinicalTrials.gov
NCT06600321Recruiting
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Updated: Oct 27, 2026
View on ClinicalTrials.gov
NCT06582017Recruiting
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Updated: Oct 20, 2026
View on ClinicalTrials.gov
NCT06330064Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Updated: Oct 26, 2026
View on ClinicalTrials.gov
NCT06265272Recruiting
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Updated: Oct 14, 2026
View on ClinicalTrials.gov
NCT06239194Recruiting
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Updated: Oct 15, 2026
View on ClinicalTrials.gov
NCT06084481Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Updated: Oct 14, 2026
View on ClinicalTrials.gov
NCT06066138Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Updated: Oct 16, 2026
View on ClinicalTrials.gov
NCT05914116Recruiting
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Updated: Oct 21, 2026
View on ClinicalTrials.gov
NCT05901519Recruiting
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Updated: Oct 15, 2026
View on ClinicalTrials.gov
NCT05440708Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Updated: Oct 22, 2026
View on ClinicalTrials.gov
NCT05003895Recruiting
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Updated: Oct 16, 2026
View on ClinicalTrials.gov
NCT04933435Recruiting
Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
Updated: Oct 22, 2026
View on ClinicalTrials.gov
NCT04792463Recruiting
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Updated: Oct 16, 2026
View on ClinicalTrials.gov
NCT04587739Recruiting
Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study.
Updated: Oct 26, 2026
View on ClinicalTrials.gov
NCT04472767Recruiting
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
Updated: Oct 26, 2026
View on ClinicalTrials.gov
NCT03432806Recruiting
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Updated: Oct 13, 2026
View on ClinicalTrials.gov